Putative Mechanisms of Cognitive Dysfunction in Chemotherapy-Naïve Diffuse Large B-Cell Lymphoma: A Case Report and Review of the Literature

REFERENCES

• Ahles, T. A., Saykin, A. J., Furstenberg, C. T., Cole, B., Mott, L. A., et al.Skalla, K., 2002. Neuropsychologic impact of standard dose chemotherapy in long-term survivors of breast cancer and lymphoma, Journal of Clinical Oncology 20 (2002), pp. 485–493.
   PubMed Web of Science ®Google Scholar
• Ahles, T. A., Saykin, A. J., McDonald, B. C., Furstenberg, C. T., Cole, B. F., et al.Hanscom, B. S., 2008. Cognitive function in breast cancer patients prior to adjuvant treatment, Breast Cancer Research and Treatment 110 (2008), pp. 143–152.
   PubMed Web of Science ®Google Scholar
• Akmansu, M., Unsal, D., Bora, H., and Elbeg, S., 2005. Influence of locoregional radiation treatment on tumor necrosis factor-α and interleukin-6 in the serum of patients with head and neck cancer, Cytokine 31 (2005), pp. 41–45.
   PubMed Web of Science ®Google Scholar
• Aleong, R., Blain, J. F., and Poirier, J., 2008. Proinflammatory cytokines modulate glial apolipoprotein E secretion, Current Alzheimer Research 5 (2008), pp. 33–37.
   PubMed Web of Science ®Google Scholar
• Alexander, S., Kerr, M. E., Kim, Y., Kamboh, M. I., Beers, S. R., and Conley, Y. P., 2007. Apolipoprotein E4 allele presence and functional outcome after severe traumatic brain injury, Journal of Neurotrauma 24 (2007), pp. 790–797.
   PubMed Web of Science ®Google Scholar
• Anthony, I. C., Crawford, D. H., and Bell, J. E., 2003. B lymphocytes in the normal brain: Contrasts with HIV-associated lymphoid infiltrates and lymphomas, Brain 126 (2003), pp. 1058–1067.
   PubMed Web of Science ®Google Scholar
• Appenzeller, S., Bertolo, M. B., and Costallat, L. T. L., 2004. Cognitive impairment in rheumatoid arthritis, Methods & Findings in Experimental & Clinical Pharmacology 26 (2004), pp. 339–343.
   PubMed Web of Science ®Google Scholar
• Bajetto, A., Bonavia, R., Barbero, S., Florio, T., and Schettini, G., 2001. Chemokines and their receptors in the central nervous system, Frontiers in Neuroendocrinology 22 (2001), pp. 147–184.
   PubMed Web of Science ®Google Scholar
• Banks, W. A., Kastin, A. J., and Gutierrez, E. G., 1993. Interleukin-1 alpha in blood has direct access to cortical brain cells, Neuroscience Letters 163 (1993), pp. 41–44.
   PubMed Web of Science ®Google Scholar
• Bolla, K. I., Rothman, R., and Cadet, J. L., 1999. Dose-related neurobehavioral effects of chronic cocaine use, Journal of Neuropsychiatry & Clinical Neurosciences 11 (1999), pp. 361–369.
   PubMed Web of Science ®Google Scholar
• Brod, S. A., Marshall, G. D., Henninger, E. M., Sriram, S., Khan, M., and Wolinsky, J. S., 1996. Interferon-β1b treatment decreases tumor necrosis factor-α and increases interleukin-6 production in multiple sclerosis, Neurology 46 (1996), pp. 1633–1638.
   PubMed Web of Science ®Google Scholar
• Brull, D. J., Montgomery, H. E., Sanders, J., Dhamrait, S., Luong, L., et al.Rumley, A., 2001. Interleukin-6 gene −174g>c and −572g>c promoter polymorphisms are strong predictors of plasma interleukin-6 levels after coronary artery bypass surgery, Arteriosclerosis, Thrombosis, & Vascular Biology 21 (2001), pp. 1458–1463.
   PubMed Web of Science ®Google Scholar
• Brunn, A., Montesinos-Rongen, M., Strack, A., Reifenberger, G., Mawrin, C., Schaller, C., and Deckert, M., 2007. Expression pattern and cellular sources of chemokines in primary central nervous system lymphoma, Acta Neuropathologica 114 (2007), pp. 271–276.
   PubMed Web of Science ®Google Scholar
• Burwick, R. M., Ramsay, P. P., Haines, J. L., Hauser, S. L., Oksenberg, J. R., et al.Pericak-Vance, M. A., 2006. APOE epsilon variation in multiple sclerosis susceptibility and disease severity: Some answers, Neurology 66 (2006), pp. 1373–1383.
   PubMed Web of Science ®Google Scholar
• Chen, Z., Malhotra, P. S., Thomas, G. R., Ondrey, F. G., Duffey, D. C., et al.Smith, C. W., 1999. Expression of proinflammatory and proangiogenic cytokines in patients with head and neck cancer, Clinical Cancer Research 5 (1999), pp. 1369–1379.
   PubMed Web of Science ®Google Scholar
• Chitnis, T., 2007. The role of CD4 T cells in the pathogenesis of multiple sclerosis, International Review of Neurobiology 79 (2007), pp. 43–72.
   PubMed Web of Science ®Google Scholar
• Cleeland, C. S., Bennett, G. J., Dantzer, R., Dougherty, P. M., Dunn, A. J., et al.Meyers, C. A., 2003. Are the symptoms of cancer and cancer treatment due to a shared biologic mechanism? A cytokine-immunologic model of cancer symptoms, Cancer 97 (2003), pp. 2919–2925.
   PubMed Web of Science ®Google Scholar
• Collins, J. S., Perry, R. T., Watson, B., Harrell, L. E., Acton, R. T., et al.Blacker, D., 2000. Association of a haplotype for tumor necrosis factor in siblings with late-onset Alzheimer's disease: The NIMH Alzheimer's disease genetics initiative, American Journal of Medical Genetics 96 (2000), pp. 823–830.
   PubMed Web of Science ®Google Scholar
• Corder, E. H., Saunders, A. M., Strittmatter, W. J., Schmechel, D. E., Gaskell, P. C., et al.Small, G. W., 1993. Gene dose of apolipoprotein E type4 allele and the risk of Alzheimer's disease in late-onset families, Science 261 (1993), pp. 921–923.
   PubMed Web of Science ®Google Scholar
• Correa, D. D., DeAngelis, L. M., Shi, W., Thaler, H. T., Lin, M., and Abrey, L. E., 2007. Cognitive functions in low-grade gliomas: Disease and treatment effects, Journal of Neuro-Oncology 81 (2007), pp. 175–184.
   PubMed Web of Science ®Google Scholar
• Coussens, L. M., and Werb, Z., 2002. Inflammation and cancer, Nature 420 (2002), pp. 860–867.
   PubMed Web of Science ®Google Scholar
• Dalakas, M. C., 2006. B cells in the pathophysiology of autoimmune neurological disorders: A credible therapeutic target, Pharmacology & Therapeutics 112 (2006), pp. 57–70.
   PubMed Web of Science ®Google Scholar
• Ellison, M. D., Krieg, R. J., and Povlishock, J. T., 1990. Differential central nervous responses following single and multiple recombinant interleukin-2 infusions, Journal of Neuroimmunology 28 (1990), pp. 259–260.
   Web of Science ®Google Scholar
• Emsley, R., Chiliza, B., and Schoeman, R., 2008. Predictors of long-term outcome in schizophrenia, Current Opinion in Psychiatry 21 (2008), pp. 173–177.
   PubMed Web of Science ®Google Scholar
• Farrar, W. L., Kilian, P. L., Ruff, M. R., Hill, J. M., and Pert, C. B., 1987. Visualization and characterization in brain of interleukin-1 receptors, Journal of Immunology 139 (1987), pp. 459–463.
   PubMed Web of Science ®Google Scholar
• Fayad, L., Cabanillas, F., Talpaz, M., McLaughin, P., and Kurzrock, R., 1998. High serum interleukin-6 levels correlate with a shorter failure-free survival in indolent lymphoma, Leukemia & Lymphoma 65 (1998), pp. 183–186.
   Google Scholar
• Ferreri, A. J. M., Blay, J. Y., Reni, M., Pasini, F., Spina, M., et al.Ambrosetti, A., 2003. Prognostic scoring system for primary CNS lymphomas: The International Extranodal Lymphoma Study Group experience, Journal of Clinical Oncology 21 (2003), pp. 266–272.
   PubMed Web of Science ®Google Scholar
• Forton, D. M., Allsop, J. M., Cox, I. J., Hamilton, G., Wesnes, K., and Thomas, H. C.Taylor Robinson, S. D., , 2005. A review of cognitive impairment and cerebral metabolite abnormalities in patients with hepatitis C infection, AIDS 19 (Suppl. 3) (2005), pp. S53–S63.
   PubMed Web of Science ®Google Scholar
• Gatter, K. C., and Warnke, R. A., 2001. "Diffuse large cell lymphoma". In: Jaffe, E. S., Harris, N. L., Stein, H., , ed. Pathology and genetics of tumors of hematopoietic and lymphoid tissues. Lyon, France: IARC Press; 2001. pp. 171–174, In, (Eds.).
   Google Scholar
• Gregor, A., Cull, A., Stephens, R. J., Kirkpatrick, J. A., Yarnold, J. R., et al.Girling, D. J., 1997. Prophylactic cranial irradiation is indicated following complete response to induction therapy in small-cell lung cancer: Results of a multicenter randomized trial: United Kingdom Coordinating Committee for Cancer Research (UKCCCR) and the European Organization for Research and Treatment of Cancer (EORTC), European Journal of Cancer 33 (1997), pp. 1752–1758.
   PubMed Web of Science ®Google Scholar
• Grimaldi, L. M. E., Casadei, C. M., Ferri, C., Veglia, F., Licastro, F., et al.Annoni, G., 2000. Association of early-onset Alzheimer's disease with an interleukin-1 α gene polymorphism, Annals of Neurology 47 (2000), pp. 361–365.
   PubMed Web of Science ®Google Scholar
• Grom, A. A., Murray, K. J., Luyrink, L., Emery, H., Passo, M. H., et al.Glass, D. N., 1996. Patterns of expression of tumor necrosis factor alpha, tumor necrosis factor beta, and their receptors in synovia of patients with juvenile rheumatoid arthritis and juvenile spondylarthropathy, Arthritis & Rheumatism 39 (1996), pp. 1703–1710.
   PubMed Web of Science ®Google Scholar
• Gutierrez, E. G., Banks, W. A., and Kastin, A. J., 1993. Murine tumor necrosis factor alpha is transported from blood to brain in the mouse, Journal of Neuroimmunology 47 (1993), pp. 169–176.
   PubMed Web of Science ®Google Scholar
• Hallahan, D. E., 1996. Radiation-mediated gene expression in the pathogenesis of the clinical radiation response, Seminars in Radiation Oncology 6 (1996), pp. 250–267.
   PubMedGoogle Scholar
• Hama, T., Kushima, Y., Miyamoto, M., Kubota, M., Takei, N., and Hatanaka, H., 1991. Interleukin-6 improves the survival of mesencephalic catecholaminergic and septal cholinergic neurons from postnatal, two-week-old rats in cultures, Neuroscience 40 (1991), pp. 445–452.
   PubMed Web of Science ®Google Scholar
• Hansen, A., Lipsky, P. E., and Dorner, T., 2007. B-cell lymphoproliferation in chronic inflammatory rheumatic diseases, Nature Clinical Practice Rheumatology 3 (2007), pp. 561–569.
   PubMedGoogle Scholar
• Harder, H., Cornelissen, J. J., van Gool, A. R., Duivenvoorden, H. J., Eijkenboom, W. M. H., and van den Bent, M. J., 2002. Cognitive functioning and quality of life in long-term adult survivors of bone marrow transplantation, Cancer 95 (2002), pp. 183–192.
   PubMed Web of Science ®Google Scholar
• Harder, H., Duivenvoorden, H. J., van Gool, A. R., Cornelissen, J. J., and van den Bent, M. J., 2006. Neurocognitive functions and quality of life in hematological patients receiving hematopoietic stem cell grafts: A one-year follow-up pilot study, Journal of Clinical and Experimental Neuropsychology 28 (2006), pp. 283–293.
   PubMed Web of Science ®Google Scholar
• Hauser, S. L., Waubant, E., Arnold, D. L., Vollmer, T., Antel, J., et al.Fox, R. J., 2008. B-cell depletion with Rituximab in relapsing-remitting multiple sclerosis, New England Journal of Medicine 358 (2008), pp. 676–688.
   PubMed Web of Science ®Google Scholar
• Hensley, M. L., Correa, D. D., Thaler, H., Wilton, A., Venkatraman, E., et al.Sabbatini, P., 2006. Phase I/II study of weekly paclitaxel plus carboplatin and gemcitabine as first-line treatment of advanced-stage ovarian cancer: Pathologic complete response and longitudinal assessment of impact on cognitive functioning, Gynecologic Oncology 102 (2006), pp. 270–277.
   PubMed Web of Science ®Google Scholar
• Hermelink, K., Untch, M., Lux, M. P., Kreienberg, R., Beck, T., Bauerfeind, I., and Münzel, K., 2007. Cognitive function during neoadjuvant chemotherapy for breast cancer: Results of a prospective, multicenter, longitudinal study, Cancer 109 (2007), pp. 1905–1913.
   PubMed Web of Science ®Google Scholar
• Heyer, E. J., Wilson, D. A., Sahlein, D. H., Mocco, J., Williams, S. C., et al.Sciacca, R., 2005. APOE-ϵ4 predisposes to cognitive dysfunction following uncomplicated carotid endarterectomy, Neurology 65 (2005), pp. 1759–1763.
   PubMed Web of Science ®Google Scholar
• Ishihara, K., and Hirano, T., 2002. IL-6 in autoimmune disease and chronic inflammatory proliferative disease, Cytokine & Growth Factor Reviews 13 (2002), pp. 357–368.
   PubMed Web of Science ®Google Scholar
• Ito, H., and Miki, C., 1999. Profile of circulating levels of interleukin-1 receptor antagonist and interleukin-6 in colorectal cancer patients, Scandinavian Journal of Gastroenterology 34 (1999), pp. 1139–1143.
   PubMed Web of Science ®Google Scholar
• Jaffe, E. S., 1987. Malignant lymphomas: Pathology of hepatic involvement, Seminars in Liver Disease 7 (1987), pp. 257–268.
   PubMed Web of Science ®Google Scholar
• Jahromi, M. M., Millward, B. A., and Demaine, A. G., 2000. A polymorphism in the promoter region of the gene for interleukin-6 is associated with susceptibility to type 1 diabetes mellitus, Journal of Interferon & Cytokine Research 20 (2000), pp. 885–888.
   PubMed Web of Science ®Google Scholar
• Jovanovski, D., Erb, S., and Zakzanis, K. K., 2005. Neurocognitive deficits in cocaine users: A quantitative review of the evidence, Journal of Clinical & Experimental Neuropsychology 27 (2005), pp. 189–204.
   PubMed Web of Science ®Google Scholar
• Kato, H., Kinoshita, T., Suzuki, S., Nagasaka, T., Hatano, S., et al.Murate, T., 1998. Production and effects of interleukin-6 and other cytokines in patients with non-Hodgkin's lymphoma, Leukemia & Lymphoma 29 (1998), pp. 71–79.
   PubMed Web of Science ®Google Scholar
• Kaul, M., 2008. HIV's double strike at the brain: Neuronal toxicity and compromised neurogenesis, Frontiers in Bioscience 13 (2008), pp. 2484–2494.
   PubMed Web of Science ®Google Scholar
• Kayl, A. E., Wefel, J. S., and Meyers, C. A., 2006. Chemotherapy and cognition: Effects, potential mechanisms, and management, American Journal of Therapeutics 13 (2006), pp. 362–369.
   PubMedGoogle Scholar
• Khuntia, D., Brown, P., Li, J., and Mehta, M. P., 2006. Whole-brain radiotherapy in the management of brain metastasis, Journal of Clinical Oncology 24 (2006), pp. 1295–1304.
   PubMed Web of Science ®Google Scholar
• Knijff, E. M., Breunis, M. N., Kupka, R. W., de Wit, H. J., Ruwhof, C., et al.Akkerhuis, G. W., 2007. An imbalance in the production of IL-1b and IL-6 by monocytes of bipolar patients: Restoration by lithium treatment, Bipolar Disorders 9 (2007), pp. 743–753.
   PubMed Web of Science ®Google Scholar
• Komaki, R., Meyers, C. A., Shin, D. M., Garden, A. S., Byrne, K., Nickens, J. A., and Cox, J. D., 1995. Evaluation of cognitive function in patients with limited small-cell lung cancer prior to and shortly following prophylactic cranial irradiation, International Journal of Radiation Oncology, Biology, & Physics 33 (1995), pp. 179–182.
   PubMed Web of Science ®Google Scholar
• Kurzrock, R., 2001. Cytokine deregulation in cancer, Biomedicine & Pharmacotherapy 55 (2001), pp. 543–547.
   PubMed Web of Science ®Google Scholar
• Lelis, R. G. B., Krieger, J. E., Pereira, A. C., Schmidt, A. P., Carmona, M. J., Oliveira, S. A., and Auler, J. O. C., 2006. Apolipoprotein E4 genotype increases the risk of postoperative cognitive dysfunction in patients undergoing coronary artery bypass graft surgery, Journal of Cardiovascular Surgery 47 (2006), pp. 451–456.
   PubMed Web of Science ®Google Scholar
• Licastro, F., Pedrini, S., Bonafe, M., Grimaldi, L. M. E., Olivieri, F., et al.Cavallone, L., 2000. Polymorphisms of the IL-6 gene increase the risk for late-onset Alzheimer's disease and affect IL-6 plasma levels, Neurobiology of Aging 21 (1S) (2000), p. S38.
   Google Scholar
• Lim, G. P., Yang, F., Chu, T., Chen, P., Beech, W., et al.Teter, B., 2000. Ibuprofen suppresses plaque pathology and inflammation in a mouse model for Alzheimer's disease, Journal of Neuroscience 20 (2000), pp. 5709–5714.
   PubMed Web of Science ®Google Scholar
• Linker-Israeli, M., Wallace, D. J., Prehn, J., Michael, D., Honda, M., et al.Taylor, K. D., 1999. Association of IL-6 gene alleles with systemic lupus erythematosus (SLE) and with elevated IL-6 expression, Genes & Immunology 1 (1999), pp. 45–52.
   PubMed Web of Science ®Google Scholar
• Llorente, A., Brouwers, P., Thompson, B., Cheng, I., Macmillan, C., et al.LaRussa, P., 2006. Effects of polymorphisms of chemokine receptors on neurodevelopment and the onset of encephalopathy in children with perinatal HIV-1 infection, Applied Neuropsychology 13 (2006), pp. 180–189.
   PubMed Web of Science ®Google Scholar
• Louko, A. M., Vilkki, J., and Niskakangas, T., 2006. ApoE genotype and cognition after subarachnoid hemorrhage: A longitudinal study, Acta Neurologica Scandinavica 114 (2006), pp. 315–319.
   PubMed Web of Science ®Google Scholar
• Mace, B. E., Wang, H., Lynch, J. R., Moss, J., and Sullivan, P.Colton, H., , 2007. Apolipoprotein E modifies the CNS response to injury via a histamine-mediated pathway, Neurological Research 29 (2007), pp. 243–250.
   PubMed Web of Science ®Google Scholar
• McGeer, P. L., and McGeer, E. G., 2001. Inflammation, autotoxicity, and Alzheimer's disease, Neurobiology of Aging 22 (2001), pp. 799–809.
   PubMed Web of Science ®Google Scholar
• Meinl, E., Krumbholz, M., and Hohlfeld, R. B., 2006. Lineage cells in the inflammatory central nervous system environment: Migration, maintenance, local antibody production, and therapeutic modulation, Annals of Neurology 59 (2006), pp. 880–892.
   PubMed Web of Science ®Google Scholar
• Merill, J. E., 1992. Tumor necrosis factor alpha, interleukin 1, and related cytokines in brain development: Normal and pathological, Developmental Neuroscience 14 (1992), pp. 1–10.
   PubMed Web of Science ®Google Scholar
• Meyers, C. A., Albitar, M., and Estey, E., 2005. Cognitive impairment, fatigue, and cytokine levels in patients with acute myelogenous leukemia or myelodysplastic syndrome, Cancer 104 (2005), pp. 788–793.
   PubMed Web of Science ®Google Scholar
• Meyers, C. A., Byrne, K. S., and Komaki, R., 1995. Cognitive deficits in patients with small-cell lung cancer before and after chemotherapy, Lung Cancer 12 (1995), pp. 231–235.
   PubMed Web of Science ®Google Scholar
• Mines, M., Ding, Y., and Fan, G. H., 2007. The many roles of chemokine receptors in neurodegenerative disorders: Emerging new therapeutical strategies, Current Medicinal Chemistry 14 (2007), pp. 2456–2470.
   PubMed Web of Science ®Google Scholar
• Mueller, C. G., Boix, C., Kwan, W. H., Daussy, C., Fournier, E., Fridman, W. H., and Molina, T. J., 2007. Critical role of monocytes to support normal B-cell and diffuse large B-cell lymphoma survival and proliferation, Journal of Leukocyte Biology 82 (2007), pp. 567–575.
   PubMed Web of Science ®Google Scholar
• Muraguchi, A., Hirano, T., Tang, U., Matsuda, T., Horii, Y., Nakajima, K., and Kishimoto, T., 1988. The essential role of B-cell stimulating factor 2 (BSF-2/IL-6) for the terminal differentiation of B cells, Journal of Experimental Medicine 167 (1988), pp. 332–344.
   PubMed Web of Science ®Google Scholar
• Akiyama, H., Barger, S., Barnum, S., Bradt, B., and Bauer, J.Cole, G. M., , 2000. Inflammation and Alzheimer's disease, Neurobiology of Aging 21 (2000), pp. 383–421Neuroinflammation Working Group.
   PubMed Web of Science ®Google Scholar
• Nikbin, B., Bonab, M. M., Khosravi, F., and Talebian, F., 2007. Role of B cells in pathogenesis of multiple sclerosis, International Review of Neurobiology 79 (2007), pp. 13–42.
   PubMed Web of Science ®Google Scholar
• Nishiyama, H., Tanei, R., Motegi, T., Ohta, M., and Sawabe, M., 2004. Angiotropic B-cell lymphoma with telangiectasia, accompanied by panniculitic formation, Journal of Dermatology 31 (2004), pp. 1032–1035.
   PubMed Web of Science ®Google Scholar
• Norris, J. G., and Benveniste, E. N., 1993. Interleukin-6 production by astrocytes: Induction by the neurotransmitter norepinephrine, Journal of Neuroimmunology 45 (1993), pp. 137–146.
   PubMed Web of Science ®Google Scholar
• Odemis, V., Moepps, B., Gierschik, P., and Engele, J., 2002. Interleukin-6 and cAMP induce stromal cell-derived factor-1 chemotaxis in astroglia by up-regulating CXCR4 cell surface expression: Implications for brain inflammation, Journal of Biological Chemistry 277 (2002), pp. 39801–39808.
   PubMed Web of Science ®Google Scholar
• O'Hara, R., Schroder, C. M., Kraemer, H. C., Kryla, N., Cao, C., et al.Miller, E., 2005. Nocturnal sleep apnea/hypopnea is associated with lower memory performance in APOE epsilon4 carriers, Neurology 65 (2005), pp. 642–644.
   PubMed Web of Science ®Google Scholar
• O'Hara, R. M., Benoit, S. E., Groves, C. J., and Collins, M., 2006. Cell-surface and cytokine biomarkers in autoimmune and inflammatory diseases, Drug Discovery Today 11 (2006), pp. 342–347.
   PubMed Web of Science ®Google Scholar
• O'Mahony, J. F., 2005. Cognitive performance and liver function among recently abstinent alcohol abusers, Addictive Behaviors 30 (2005), pp. 369–373.
   PubMed Web of Science ®Google Scholar
• Padmos, R. C., Bekris, L., Knijff, E. M., Tiemeier, H., Kupka, R. W., et al.Cohen, D., 2004. A high prevalence of organ-specific autoimmunity in patients with bipolar disorder, Biological Psychiatry 56 (2004), pp. 476–482.
   PubMed Web of Science ®Google Scholar
• Pavol, M. A., Meyers, C. A., Rexer, J. L., Valentine, A. D., Mattis, P. J., and Talpaz, M., 1995. Pattern of neurobehavioral deficits associated with interferon alpha therapy for leukemia, Neurology 45 (1995), pp. 947–950.
   PubMed Web of Science ®Google Scholar
• Potvin, S., Stip, E., Sepehry, A. A., Gendron, A., Bah, R., and Kouassi, E., 2008. Inflammatory cytokine alterations in schizophrenia: A systematic quantitative review, Biological Psychiatry 63 (2008), pp. 801–808.
   PubMed Web of Science ®Google Scholar
• Rachal Pugh, C., Fleshner, M., Watkins, L. R., Maier, S. F., and Rudy, J. W., 2001. The immune system and memory consolidation: A role for the cytokine IL-1β, Neuroscience and Biobehavioral Reviews 25 (2001), pp. 29–41.
   PubMed Web of Science ®Google Scholar
• Rahman, A., and Isenberg, D. A., 2008. Systemic lupus erythematosus, New England Journal of Medicine 358 (2008), pp. 929–939.
   PubMed Web of Science ®Google Scholar
• Ransohoff, R. M., and Benveniste, E. N., 1996. Cytokines in the CNS. Boca Raton, FL: CRC Press; 1996.
   Google Scholar
• Rosengren, S., Firestein, G. S., and Boyle, D. L., 2003. Measurement of inflammatory biomarkers in synovial tissue extracts by enzyme-linked immunosorbent assay, Clinical and Diagnostic Laboratory Immunology 10 (2003), pp. 1002–1010.
   PubMedGoogle Scholar
• Schram, M. T., Euser, S. M., de Craen, A. J., Witteman, J. C., Frolich, M., et al.Hofman, A., 2007. Systemic markers of inflammation and cognitive decline in old age, Journal of the American Geriatrics Society 55 (2007), pp. 708–716.
   PubMed Web of Science ®Google Scholar
• Schror, K., 2007. Aspirin and Reye syndrome: A review of the evidence, Pediatric Drugs 9 (2007), pp. 195–204.
   PubMedGoogle Scholar
• Solomon, T. M., and Halkitis, P. N., 2008. Cognitive executive functioning in relation to HIV medication adherence among gay, bisexual, and other men who have sex with men, AIDS & Behavior 12 (2008), pp. 68–77.
   PubMed Web of Science ®Google Scholar
• Stern, A. S., Magram, J., and Presky, D. I. I., 1996. Interleukin-12: An integral cytokine in the immune response, Life Sciences 58 (1996), pp. 639–654.
   PubMed Web of Science ®Google Scholar
• Sternberg, E. M., 2006. Neural regulation of innate immunity: A coordinated nonspecific host response to pathogens, Nature Reviews Immunology 6 (2006), pp. 318–328.
   PubMed Web of Science ®Google Scholar
• Stubner, S., Schon, T., Padberg, F., Teipel, S. J., Schwarz, M. J., et al.Haslinger, A., 1999. Interleukin-6 and the soluble IL-6 receptor are decreased in cerebrospinal fluid of geriatric patients with major depression: No alteration of soluble gp130, Neuroscience Letters 259 (1999), pp. 145–148.
   PubMed Web of Science ®Google Scholar
• Stuve, O., Cepok, S., Elias, S., Saleh, A., Hartung, H. P., Hemmer, B., and Kieseier, B. C., 2005. Clinical stabilization and effective B-lymphocyte depletion in the cerebrospinal fluid and peripheral blood of a patient with fulminant relapsing-remitting multiple sclerosis, Archives of Neurology 62 (2005), pp. 1620–1623.
   PubMed Web of Science ®Google Scholar
• Suarez Krabbe, K., Reichenberg, A., Yirmiya, R., Smed, A., Klarlund Pedersen, B., and Bruunsgaard, H., 2005. Low-dose endotoxemia and human neuropsychological functions, Brain, Behavior, and Immunity 19 (2005), pp. 453–460.
   PubMed Web of Science ®Google Scholar
• Sutherland, A. P., Mackay, F., and Mackay, C. R., 2006. Targeting BAFF: Immunomodulation for autoimmune diseases and lymphomas, Pharmacology & Therapeutics 112 (2006), pp. 774–786.
   PubMed Web of Science ®Google Scholar
• Tan, J. H., Goh, B. C., Tambyah, P. A., and Wilder-Smith, E., 2005. Paraneoplastic progressive supranuclear palsy syndrome in a patient with B-cell lymphoma, Parkinsonism and Related Disorders 11 (2005), pp. 187–191.
   PubMed Web of Science ®Google Scholar
• Tchen, N., Juffs, H. G., Downie, F. P., Yi, Q. L., Hu, H., et al.Chemerynsky, I., 2003. Cognitive function, fatigue, and menopausal symptoms in women receiving adjuvant chemotherapy for breast cancer, Journal of Clinical Oncology 21 (2003), pp. 4175–4183.
   PubMed Web of Science ®Google Scholar
• Tomietto, P., Annese, V., D'Agostini, S., Venturini, P., La Torre, G., De Vita, S., and Ferraccioli, G. F., 2007. General and specific factors associated with severity of cognitive impairment in systemic lupus erythematosus, Arthritis & Rheumatism 57 (2007), pp. 1461–1472.
   PubMed Web of Science ®Google Scholar
• Trompet, S., de Craen, A. J. M., Slagboom, P., Shepherd, J., Blauw, G. J., et al.Murphy, M. B., 2008. Genetic variation in the interleukin-1b-converting enzyme associates with cognitive function. The PROSPER study, Brain 131 (2008), pp. 1069–1077, and on behalf of the PROSPER Group.
   PubMed Web of Science ®Google Scholar
• Vandenbroeck, K., Fiten, P., Ronsse, I., Goris, A., Porru, I., et al.Melis, C., 2000. High-resolution analysis of IL-6 minisatellite polymorphism in Sardinian multiple sclerosis: Effect on course and onset of disease, Genes & Immunity 1 (2000), pp. 460–463.
   PubMed Web of Science ®Google Scholar
• Viviani, B.Gardoni, F., , 2007. Cytokines and neuronal ion channels in health and disease, International Review of Neurobiology 82 (2007), pp. 247–263.
   PubMed Web of Science ®Google Scholar
• Vogels, R. L., Oosterman, J. M., van Harten, B., Scheltens, P., van der Flier, W. M., et al.Schroeder-Tanka, J. M., 2007. Profile of cognitive impairment in chronic heart failure, Journal of the American Geriatrics Society 55 (2007), pp. 1764–1770.
   PubMed Web of Science ®Google Scholar
• Weeraratna, A. T., Kalehua, A., Deleon, I., Bertak, D., Maher, G., et al.Wade, M. S., 2007. Alterations in immunological and neurological gene expression patterns in Alzheimer's disease tissues, Experimental Cell Research 313 (2007), pp. 450–461.
   PubMed Web of Science ®Google Scholar
• Wefel, J. S., Lenzi, R., Theriault, R. L., Davis, R. N., and Meyers, C. A., 2004. The cognitive sequelae of standard-dose adjuvant chemotherapy in women with breast carcinoma: Results of a prospective, randomized, longitudinal trial, Cancer 100 (2004), pp. 2292–2299.
   PubMed Web of Science ®Google Scholar
• Wyss-Coray, T., Borrow, P., Brooker, M. J., and Mucke, L., 1997. Astroglial overproduction of TGF-beta 1 enhances inflammatory central nervous system disease in transgenic mice, Journal of Neuroimmunology 77 (1997), pp. 45–50.
   PubMed Web of Science ®Google Scholar
• Zalcman, S., Green-Johnson, J. M., Murray, L., Nance, D. M., Dyck, D., Anisman, H., and Greenberg, A. H., 1994. Cytokine-specific central monoamine alterations induced by interleukin-1, -2 and -6, Brain Research 643 (1994), pp. 40–49.
   PubMed Web of Science ®Google Scholar
• Zhang, J., Roschke, V., Baker, K. P., Wang, Z., Alarcon, G. S., et al.Fessler, B. J., 2001. Cutting edge: A role for B lymphocyte stimulator in systemic lupus erythematosus, Journal of Immunology 166 (2001), pp. 6–10.
   PubMed Web of Science ®Google Scholar
• Zhang, X. Y., Zhou, D. F., Zhang, P. Y., Wu, G. Y., Cao, L. Y., and Shen, Y. C., 2002. Elevated interleukin-2, interleukin-6, and interleukin-8 serum levels in neuroleptic-free schizophrenia: Association with psychopathology, Schizophrenia Research 57 (2002), pp. 247–258.
   PubMed Web of Science ®Google Scholar